Gene · 4214
Papers4,517
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,517
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. | Sci Rep | 2023 | 37925483 | PubTator, text mining | PubMed |
| Multi-scale characterisation of homologous recombination deficiency in breast cancer. | Genome Med | 2023 | 37919776 | PubTator, text mining | PubMed |
| p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. | Cell Commun Signal | 2023 | 37919729 | PubTator, text mining | PubMed |
| TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease. | Front Vet Sci | 2023 | 37908840 | PubTator, text mining | PubMed |
| Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China. | Front Oncol | 2023 | 37901334 | PubTator, text mining | PubMed |
| Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A. | Front Cell Dev Biol | 2023 | 37900285 | PubTator, text mining | PubMed |
| HOMA-IR is positively correlated with biological age and advanced aging in the US adult population. | Eur J Med Res | 2023 | 37898776 | PubTator, text mining | PubMed |
| Navigating the ERK1/2 MAPK Cascade. | Biomolecules | 2023 | 37892237 | PubTator, text mining | PubMed |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. | Cancer Cell | 2023 | 37890493 | PubTator, text mining | PubMed |
| ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance. | Discov Oncol | 2023 | 37875591 | PubTator, text mining | PubMed |
| Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review. | Front Oncol | 2023 | 37869099 | PubTator, text mining | PubMed |
| Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer. | Front Immunol | 2023 | 37868988 | PubTator, text mining | PubMed |
| MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia. | Cancer Rep (Hoboken) | 2023 | 37867416 | PubTator, text mining | PubMed |
| Metabolic stratification of human breast tumors reveal subtypes of clinical and therapeutic relevance. | iScience | 2023 | 37854701 | PubTator, text mining | PubMed |
| Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications. | Aging (Albany NY) | 2023 | 37847185 | PubTator, text mining | PubMed |
| Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed? | Nat Prod Bioprospect | 2023 | 37843642 | PubTator, text mining | PubMed |
| A case of 46,XY complete gonadal dysgenesis with a novel missense variant in SRY. | Clin Pediatr Endocrinol | 2023 | 37842143 | PubTator, text mining | PubMed |
| Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence? | Neurobiol Stress | 2023 | 37842017 | PubTator, text mining | PubMed |
| Exosomes as a delivery tool of exercise-induced beneficial factors for the prevention and treatment of cardiovascular disease: a systematic review and meta-analysis. | Front Physiol | 2023 | 37841310 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4214/papers?page=11